Marino Stram & Associates’s Chemed CHE Stock Holding History

Marino Stram & Associates’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-17	Closed	-$5K	–	155
2019 Q1	$5K	Buy	17 +1	+6%	+$307	﹤0.01%	360
2018 Q4	$5K	Buy	+16	New	+$4.83K	﹤0.01%	331

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Marino Stram & Associates's CHE Position: Q2 2019 in Review

Marino Stram & Associates sold out of Chemed (CHE) in Q2 2019, closing a stake of 17 shares — an estimated $5K sold.

Marino Stram & Associates first reported a position in CHE in Q4 2018 and held it in 2 quarters. The position peaked at $5K in Q1 2019. 370 funds tracked by Wall St. Rank hold CHE as of Q2 2019.

Marino Stram & Associates reported no remaining Chemed position as of Q2 2019 after selling out during the quarter.
Marino Stram & Associates sold 17 Chemed shares in Q2 2019, an estimated $5K.
Marino Stram & Associates first reported a position in Chemed in Q4 2018 and held it in 2 quarters.
Marino Stram & Associates's Chemed position peaked at $5K in Q1 2019.
370 funds tracked by Wall St. Rank held Chemed as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.